DK0510748T3 - Anvendelse af en methoxyalkansyre af indazol til fremstilling af et lægemiddel til behandling af autoimmune sygdomme - Google Patents

Anvendelse af en methoxyalkansyre af indazol til fremstilling af et lægemiddel til behandling af autoimmune sygdomme

Info

Publication number
DK0510748T3
DK0510748T3 DK92201037.6T DK92201037T DK0510748T3 DK 0510748 T3 DK0510748 T3 DK 0510748T3 DK 92201037 T DK92201037 T DK 92201037T DK 0510748 T3 DK0510748 T3 DK 0510748T3
Authority
DK
Denmark
Prior art keywords
medicament
manufacture
treatment
autoimmune diseases
indazole
Prior art date
Application number
DK92201037.6T
Other languages
English (en)
Inventor
Bruno Silvestrini
Original Assignee
Angelini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa
Application granted granted Critical
Publication of DK0510748T3 publication Critical patent/DK0510748T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92201037.6T 1991-04-22 1992-04-11 Anvendelse af en methoxyalkansyre af indazol til fremstilling af et lægemiddel til behandling af autoimmune sygdomme DK0510748T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911101A IT1253703B (it) 1991-04-22 1991-04-22 Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie

Publications (1)

Publication Number Publication Date
DK0510748T3 true DK0510748T3 (da) 1996-07-22

Family

ID=11359721

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92201037.6T DK0510748T3 (da) 1991-04-22 1992-04-11 Anvendelse af en methoxyalkansyre af indazol til fremstilling af et lægemiddel til behandling af autoimmune sygdomme

Country Status (16)

Country Link
US (1) US5278183A (da)
EP (1) EP0510748B1 (da)
JP (1) JP3056879B2 (da)
KR (1) KR100210199B1 (da)
AT (1) ATE135573T1 (da)
AU (1) AU657524B2 (da)
BG (1) BG61366B2 (da)
CA (1) CA2066304C (da)
CZ (1) CZ280613B6 (da)
DE (1) DE69209128T2 (da)
DK (1) DK0510748T3 (da)
IL (1) IL101660A (da)
IT (1) IT1253703B (da)
NZ (1) NZ242392A (da)
SK (1) SK278546B6 (da)
ZA (1) ZA922740B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723315B1 (fr) * 1994-08-02 1996-10-25 Cird Galderma Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
JP2005510492A (ja) * 2001-10-26 2005-04-21 ユニバーシティ オブ コネチカット 新規な種類の効力のあるカンナビミメティックリガンド
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
US8314099B2 (en) 2008-03-07 2012-11-20 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
BRPI0907976A2 (pt) 2008-03-07 2015-08-04 Acraf Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
JP5509100B2 (ja) 2008-03-07 2014-06-04 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニ 新規な1−ベンジル−3−ヒドロキシメチルインダゾール誘導体及びそのMCP−1,CX3CR1及びp40の発現に基づく疾病の治療への使用
PL2462118T3 (pl) 2009-08-03 2014-10-31 Acraf Sposób wytwarzania 1-benzylo-3-hydroksymetylo-1H-indazolu i jego pochodnych oraz potrzebnych magnezowych związków pośrednich
UA108742C2 (uk) * 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CA3144861A1 (en) 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194564B (it) * 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
DE3664036D1 (en) * 1985-02-12 1989-07-27 Acraf (1-phenylmethyl-5-hydroxy-1h-indazol-3-yl)-oxyacetic acid and salts thereof for use as a medicament, and pharmaceutical compositions containing them
IT1230441B (it) * 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo

Also Published As

Publication number Publication date
BG61366B2 (bg) 1997-06-30
ZA922740B (en) 1992-12-30
CA2066304C (en) 2005-06-21
CZ280613B6 (cs) 1996-03-13
NZ242392A (en) 1997-06-24
CA2066304A1 (en) 1992-10-23
JP3056879B2 (ja) 2000-06-26
ITMI911101A0 (it) 1991-04-22
AU1488392A (en) 1992-10-29
SK278546B6 (en) 1997-09-10
EP0510748A1 (en) 1992-10-28
DE69209128T2 (de) 1996-11-28
JPH0640915A (ja) 1994-02-15
US5278183A (en) 1994-01-11
ITMI911101A1 (it) 1992-10-22
ATE135573T1 (de) 1996-04-15
KR920019350A (ko) 1992-11-19
KR100210199B1 (ko) 1999-07-15
CS122792A3 (en) 1992-11-18
IT1253703B (it) 1995-08-23
AU657524B2 (en) 1995-03-16
DE69209128D1 (de) 1996-04-25
EP0510748B1 (en) 1996-03-20
IL101660A (en) 1996-08-04

Similar Documents

Publication Publication Date Title
DK0510748T3 (da) Anvendelse af en methoxyalkansyre af indazol til fremstilling af et lægemiddel til behandling af autoimmune sygdomme
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
DK0517876T3 (da) Terapeutiske benzazepinforbindelser
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
EP0201349A3 (en) Tetrazole derivatives
NO985063L (no) Pyridyl- og pyrimidyl-piperaziner i behandling av substansmisbruks forstyrr
DE69219219T2 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE3884878D1 (de) Uricosuretische Zusammensetzung.
MY108455A (en) Therapeutic benzazapine compounds.